Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05459870
PHASE1/PHASE2

CAR-T Cells Targeting Autoimmune Diseases

Sponsor: Shenzhen Geno-Immune Medical Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the feasibility, safety and efficacy of CAR-T cell therapy in patients with autoimmune disease. Another goal of the study is to learn more about the safety and function of the CAR-T cells and their persistency in autoimmune disease patients.

Official title: CAR-T Cells Targeting B Cell Related Autoimmune Diseases

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2022-07-31

Completion Date

2026-06-30

Last Updated

2022-07-19

Healthy Volunteers

No

Interventions

BIOLOGICAL

4SCAR T cells

Infusion of 4SCAR T cells at 10\^6 cells/kg body weight via IV

Locations (2)

Shenzhen Geno-immune Medical Institute

Shenzhen, Guangdong, China

Guilin Hospital of Chinese Traditional and Western Medicine

Guilin, Guangxi, China